Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$6M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 17 most recent Form 4 transactions.
| May 18 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 10,456 | $64.82 | $677.7K | -2.8% | Open the original filing on SEC.gov |
| May 16 | BBIO | BridgeBio Pharma, Inc. | FTAX◷ | 22,781 | $66.13 | $1.5M | -5.8% | Open the original filing on SEC.gov |
| Mar 18 | BBIO | BridgeBio Pharma, Inc. | AGRANT | 59,041 | — | — | +17.5% | Open the original filing on SEC.gov |
| Feb 17 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 200 | $75.38 | $15.1K | <0.1% | Open the original filing on SEC.gov |
| Feb 17 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 13,400 | $74.71 | $1M | -3.8% | Open the original filing on SEC.gov |
| Feb 16 | BBIO | BridgeBio Pharma, Inc. | FTAX◷ | 18,819 | $75.25 | $1.4M | -5.1% | Open the original filing on SEC.gov |
| Dec 12, 2025 | BBIO | BridgeBio Pharma, Inc. | FTAX | 13,826 | $75.15 | $1M | -3.6% | Open the original filing on SEC.gov |
| Nov 17, 2025 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 6,956 | $66.84 | $464.9K | -1.8% | Open the original filing on SEC.gov |
| Nov 17, 2025 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 9,978 | $66.19 | $660.5K | -2.5% | Open the original filing on SEC.gov |
| Nov 16, 2025 | BBIO | BridgeBio Pharma, Inc. | FTAX◷ | 21,317 | $66.39 | $1.4M | -5.1% | Open the original filing on SEC.gov |
| Aug 21, 2025 | BBIO | BridgeBio Pharma, Inc. | SSELL | 42,237 | $49.48 | $2.1M | -9.1% | Open the original filing on SEC.gov |
| Aug 18, 2025 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 1,973 | $50.94 | $100.5K | -0.4% | Open the original filing on SEC.gov |
| Aug 18, 2025 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 15,380 | $50.14 | $771.2K | -3.2% | Open the original filing on SEC.gov |
| Aug 16, 2025 | BBIO | BridgeBio Pharma, Inc. | FTAX◷ | 21,317 | $51.32 | $1.1M | -4.3% | Open the original filing on SEC.gov |
| May 16, 2025 | BBIO | BridgeBio Pharma, Inc. | FTAX | 21,317 | $33.84 | $721.4K | -4.1% | Open the original filing on SEC.gov |